Insider trades
Jason Drew Smith, General Counsel of UroGen Pharma URGN, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $147.3K. The latest trade was on 02/03.
Jason Drew Smith
General Counsel
- Company
- UroGen Pharma URGN
- First filing
- 23/02/02
- Trades
- 53 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$147.3K
- Last trade
- 02/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
URGN | Open-market sale | 02/03 | 02/11 | 7,479 sh3 trades | $19.69avg. | $147,261.51 | −11.9% |
UroGen PharmaURGN | Open-market sale | 25/09/08 | 25/09/09 | 1,520 sh | $19.11 | $29,047.2 | −3.4% |
UroGen PharmaURGN | Open-market sale | 25/07/28 | 25/07/30 | 7,522 sh | $19.14 | $143,971.08 | −15.3% |
URGN | Open-market sale | 25/01/31 | 25/02/04 | 7,379 sh3 trades | $11.14avg. | $82,202.06 | −18.5% |
UroGen PharmaURGN | Open-market sale | 24/09/09 | 24/09/12 | 1,521 sh | $13.08 | $19,894.68 | −5.7% |
URGN | Open-market saleAmendment | 24/02/01 | 24/02/05 | 4,993 sh3 trades | $15.78avg. | $78,789.54 | −17.6% |
URGN | Open-market sale | 24/01/31 | 24/02/02 | 4,993 sh3 trades | $15.74avg. | $78,589.82 | −17.6% |
UroGen PharmaURGN | Open-market sale | 23/08/31 | 23/09/05 | 3,800 sh | $18.01 | $68,438 | −17.1% |
URGN | Open-market sale | 23/01/31 | 23/02/02 | 1,636 sh2 trades | $10.12avg. | $16,556.32 | −10.5% |